Virtual Medicinal Product (VMP)
-
Cabergoline 4mg tablets
Name Details
|
Current Name
Cabergoline 4mg tablets
|
Start Date
30-10-2002
|
End Date
|
|
Previous Name
Cabergoline 4mg tablets
|
Start Date
29-10-2002
|
End Date
29-10-2002
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N04BC06
| BNF |
|
Current BNF
04090100
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
04090100
|
Start Date
23-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 41872411000001101 |
26-05-2023 |
|
| 323194009 |
29-10-2002 |
25-05-2023 |
VMP Ingredients
VMP ingredients table
| Cabergoline |
Based on Ingredient Substance |
|
4 mg |
|
Name
Cabergoline
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
4
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information